AbbVie Inc.

ABBV

$231.24

Name : AbbVie Inc.

Sector : Healthcare

Industry: Drug Manufacturers - General

Mark. Cap: $408,498,929,664.00

EPSttm : 2.1

AbbVie Inc.

$231.24

0.68%

$1.59

Float Short %

0.94

Margin Of Safety %

-6

Put/Call OI Ratio

0.74

EPS Next Q Diff

0.36

EPS Last/This Y

9.57

EPS This/Next Y

2.28

Price

231.25

Target Price

232.24

Analyst Recom

1.9

Performance Q

18.58

Relative Volume

0.8

Beta

0.5

Ticker: ABBV

23 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-09-08	ABBV	209.84	0.80	0.24	315750
2025-09-09	ABBV	210.41	0.76	0.16	328394
2025-09-10	ABBV	211.68	0.75	0.29	331871
2025-09-11	ABBV	220.22	0.75	0.39	334778
2025-09-12	ABBV	218.92	0.78	0.78	335301
2025-09-15	ABBV	217.72	0.79	0.28	331048
2025-09-16	ABBV	216.26	0.77	0.51	340514
2025-09-17	ABBV	220.81	0.7659064055283	0.42678020024329	345240
2025-09-18	ABBV	222	0.76	0.18	350087
2025-09-19	ABBV	222.4	0.75	0.34	360488
2025-09-22	ABBV	222.63	0.72	0.58	309543
2025-09-23	ABBV	222.65	0.72	0.89	314828
2025-09-24	ABBV	220.03	0.72	0.60	317388
2025-09-25	ABBV	218.49	0.72	0.56	320762
2025-09-26	ABBV	220.62	0.71	0.82	326332
2025-09-29	ABBV	223.18	0.73	0.48	323319
2025-09-30	ABBV	231.56	0.71	0.22	330507
2025-10-01	ABBV	244.38	0.76	0.35	328591
2025-10-02	ABBV	236.61	0.74	0.68	346950
2025-10-03	ABBV	233.89	0.74	0.98	352432
2025-10-06	ABBV	230.21	0.74	0.98	346314
2025-10-07	ABBV	232.83	0.75	0.43	352426
2025-10-08	ABBV	231.34	0.74	0.25	358982
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

23 items 1 of 1

23 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-09-08	ABBV	209.79	9.1	25314.1	11.97
2025-09-09	ABBV	210.41	9.1	25744.8	11.97
2025-09-10	ABBV	211.67	9.1	25825.4	11.97
2025-09-11	ABBV	220.22	9.1	26757.8	11.97
2025-09-12	ABBV	218.31	9.1	25431.8	11.97
2025-09-15	ABBV	217.71	9.0	25586.6	11.96
2025-09-16	ABBV	216.26	9.0	25497.6	11.96
2025-09-17	ABBV	220.77	9.0	26228.9	11.96
2025-09-18	ABBV	221.99	9.0	25810.7	11.96
2025-09-19	ABBV	222.38	9.0	25713.1	11.96
2025-09-22	ABBV	222.59	9.0	25680.0	11.96
2025-09-23	ABBV	222.64	9.0	25671.5	11.96
2025-09-24	ABBV	220.02	9.0	25350.3	11.96
2025-09-25	ABBV	218.54	9.0	25486.7	11.96
2025-09-26	ABBV	220.61	9.0	25921.7	11.96
2025-09-29	ABBV	223.15	9.0	25976.8	11.96
2025-09-30	ABBV	231.58	9.0	26689.8	11.96
2025-10-01	ABBV	244.39	9.0	27179.8	11.96
2025-10-02	ABBV	236.98	9.0	24833.2	11.96
2025-10-03	ABBV	233.90	9.0	25357.2	11.96
2025-10-06	ABBV	230.21	9.0	24930.3	11.96
2025-10-07	ABBV	232.88	8.9	25984.1	11.97
2025-10-08	ABBV	231.25	8.9	25480.1	11.97
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

23 items 1 of 1

23 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-09-08	ABBV	-6.37	0.11	0.96
2025-09-09	ABBV	-6.37	0.11	0.96
2025-09-10	ABBV	-6.37	0.11	0.96
2025-09-11	ABBV	-6.37	0.11	0.87
2025-09-12	ABBV	-6.37	0.11	0.87
2025-09-15	ABBV	-6.37	0.14	0.87
2025-09-16	ABBV	-6.37	0.14	0.87
2025-09-17	ABBV	-6.37	0.14	0.87
2025-09-18	ABBV	-6.37	0.14	0.87
2025-09-19	ABBV	-5.56	0.14	0.87
2025-09-22	ABBV	-5.56	0.13	0.87
2025-09-23	ABBV	-5.56	0.13	0.87
2025-09-24	ABBV	-5.56	0.13	0.87
2025-09-25	ABBV	-5.56	0.13	0.94
2025-09-26	ABBV	-5.56	0.13	0.94
2025-09-29	ABBV	-5.56	0.13	0.94
2025-09-30	ABBV	-5.56	0.13	0.94
2025-10-01	ABBV	-5.56	0.13	0.94
2025-10-02	ABBV	-6.09	0.13	0.94
2025-10-03	ABBV	-3.05	0.13	0.94
2025-10-06	ABBV	-3.05	0.09	0.94
2025-10-07	ABBV	-3.05	0.09	0.94
2025-10-08	ABBV	-3.05	0.09	0.94
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

23 items 1 of 1

Last Quarter Act. EPS

2.97

Avg. EPS Est. Current Quarter

3.27

Avg. EPS Est. Next Quarter

3.33

Insider Transactions

-3.05

Institutional Transactions

0.09

Beta

0.5

Average Sales Estimate Current Quarter

15582

Average Sales Estimate Next Quarter

16315

Fair Value

217.9

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

5.5

Max Drawdown 5-Year %

-21.9

Target Price

232.24

P/E

110.05

Forward P/E

16.17

PEG

6.79

P/S

P/B

P/Free Cash Flow

22.4

EPS

2.1

Average EPS Est. Cur. Y

11.97

EPS Next Y. (Est.)

14.25

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

6.38

Relative Volume

0.8

Return on Equity vs Sector %

-2059.6

Return on Equity vs Industry %

-2068.3

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

25480.1

AbbVie Inc.

Sector: Healthcare

Industry: Drug Manufacturers - General

Employees: 55000

AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacture, commercialization, and sale of medicines and therapies worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, generalized pustular psoriasis, and pyoderma gangrenosum; Skyrizi to treat autoimmune diseases, erythrodermic psoriasis, generalized pustular psoriasis, and palmoplantar pustulosis; Rinvoq to treat inflammatory diseases; Imbruvica for the treatment of adult patients with blood cancers; Venclexta/Venclyxto to treat blood cancers; Elahere to treat various cancer; and Epkinly to treat lymphoma. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; botox therapeutic to treat neurologic diseases; Vraylar to treat schizophrenia, bipolar disorder, and depressive disorder; Duopa and Duodopa to treat Parkinson's disease; Ubrelvy to treat migraine; and Qulipta for episodic and chronic migraine, as well as other neuroscience products. In addition, the company offers Ozurdex for eye diseases; Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; Restasis to increase tear production; and other eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus genotype 1-6 infection; Creon, a pancreatic enzyme therapy; and Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.

stock quote shares ABBV – AbbVie Inc. Stock Price stock today

news today ABBV – AbbVie Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch ABBV – AbbVie Inc. yahoo finance google finance

stock history ABBV – AbbVie Inc. invest stock market

stock prices ABBV premarket after hours

ticker ABBV fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: ABBV

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y